Published in Chest on March 02, 2009
CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med (2014) 2.50
Obstructive sleep apnea is a risk factor for Barrett's esophagus. Clin Gastroenterol Hepatol (2013) 2.11
Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest (2010) 1.79
Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea. Med Sci Monit (2012) 1.61
TST, as a polysomnographic variable, is superior to the apnea hypopnea index for evaluating intermittent hypoxia in severe obstructive sleep apnea. Eur Arch Otorhinolaryngol (2014) 1.42
Sleep and hypertension. Chest (2010) 1.24
Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. J Inflamm (Lond) (2013) 1.15
The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep (2012) 1.12
Obstructive Sleep Apnoea: From pathogenesis to treatment: Current controversies and future directions. Respirology (2010) 1.00
Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens (2011) 0.98
Obstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms. Minerva Pneumol (2009) 0.92
Obstructive sleep apnea syndrome is associated with metabolic syndrome and inflammation. Eur Arch Otorhinolaryngol (2013) 0.85
Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein. World J Exp Med (2015) 0.84
Coagulability in obstructive sleep apnea. Can Respir J (2011) 0.83
Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea. Angiology (2015) 0.81
Association between sleep quality and C-reactive protein: results from national health and nutrition examination survey, 2005-2008. PLoS One (2014) 0.81
Obstructive sleep apnea and endothelial progenitor cells. Patient Prefer Adherence (2013) 0.76
The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations. Mediators Inflamm (2016) 0.75
Obstructive Sleep Apnea Is Associated with Elevated High Sensitivity C-Reactive Protein Levels Independent of Obesity: Korean Genome and Epidemiology Study. PLoS One (2016) 0.75
The effect of continuous positive airway pressure on C-reactive protein levels in patients with obstructive sleep apnea syndrome. Chest (2010) 0.75
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea. JCI Insight (2017) 0.75
A new surgical technique versus an old marker: can expansion sphincter pharyngoplasty reduce C-reactive protein levels in patients with obstructive sleep apnea? Eur Arch Otorhinolaryngol (2016) 0.75
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Interleukin-6 and the acute phase response. Biochem J (1990) 7.97
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ (2000) 6.10
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol (2004) 6.08
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation (2001) 4.76
Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest (1988) 4.40
C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation (1999) 4.40
Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med (2003) 4.16
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation (2003) 2.98
Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation (2003) 2.71
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation (2001) 2.66
Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation (2004) 2.21
Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation (2005) 1.99
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine (2000) 1.92
C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep (2007) 1.79
Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol (2000) 1.56
Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev (1997) 1.09
Effects of long-term nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome. Intern Med (2005) 1.04
Enhanced synthesis of albumin and fibrinogen at high altitude. J Appl Physiol (1985) (2001) 0.93
Decreased lipoprotein lipase in obstructive sleep apnea syndrome. Circ J (2007) 0.91
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med (2015) 8.61
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol (2007) 7.79
Effect of altitude on leptin levels, does it go up or down? J Appl Physiol (1985) (2008) 6.68
Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA (2003) 5.39
Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77
Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med (2005) 3.84
Association of atrial fibrillation and obstructive sleep apnea. Circulation (2004) 3.81
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology (2013) 3.70
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity. Heart (2012) 3.36
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12
The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med (2007) 3.07
Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension (2005) 3.07
Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation (2003) 2.99
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol (2007) 2.99
Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86
Plasma homocysteine in obstructive sleep apnoea. Eur Heart J (2004) 2.85
Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation (2003) 2.77
Obstructive sleep apnea. Ann Intern Med (2005) 2.75
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71
Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension (2011) 2.68
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol (2005) 2.44
Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Sleep-disordered breathing and cardiovascular disease. Circulation (2003) 2.30
Obstructive sleep apnea is associated with increased high-sensitivity cardiac troponin T levels. Chest (2012) 2.21
Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation (2004) 2.21
Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol (2012) 2.15
Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc (2004) 2.14
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem (2008) 2.09
Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol (2010) 2.09
Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition (2002) 2.05
Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest (2013) 2.02
Leptin deficiency promotes central sleep apnea in patients with heart failure. Chest (2014) 1.99
Clinical scenario 1 is associated with winter onset of acute heart failure. Circ J (2014) 1.97
Dynamical description of sinoatrial node pacemaking: improved mathematical model for primary pacemaker cell. Am J Physiol Heart Circ Physiol (2002) 1.94
Sleep and cardiovascular disease. Curr Probl Cardiol (2005) 1.91
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol (2004) 1.87
Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med (2008) 1.84
Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest (2010) 1.79
Sleep-disordered breathing and cardiovascular risk. Sleep (2007) 1.77
Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens (2007) 1.74
Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J (2006) 1.73
Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail (2009) 1.73
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J (2007) 1.67
Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol (2004) 1.64
Differentiating between body fat and lean mass-how should we measure obesity? Nat Clin Pract Endocrinol Metab (2008) 1.61
C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens (2005) 1.61
Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol (2013) 1.60
Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol (2004) 1.59
Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome. Hypertens Res (2009) 1.58
Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension (2007) 1.56
Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia. Circ J (2015) 1.55
Geriatric nutritional risk index predicts functional dependency and mortality in patients with heart failure with preserved ejection fraction. Circ J (2012) 1.53
Hemophagocytic lymphohistiocytosis associated with uncontrolled inflammatory cytokinemia and chemokinemia was caused by systemic anaplastic large cell lymphoma: a case report and review of the literature. J Pediatr Hematol Oncol (2008) 1.52
Transient left ventricular apical ballooning in a patient with bicuspid aortic valve created a left ventricular thrombus leading to acute renal infarction. Circ J (2004) 1.52
Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol (2008) 1.50
Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis (2005) 1.50
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. J Hum Genet (2006) 1.48
Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest (2008) 1.47
Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure. Eur J Heart Fail (2013) 1.47
Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure. J Card Fail (2005) 1.46
Interatrial pressure gradients during simulated obstructive sleep apnea: a catheter-based study. Catheter Cardiovasc Interv (2014) 1.45
Resting sympathetic outflow does not predict the morning blood pressure surge in hypertension. J Hypertens (2011) 1.45
Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail (2010) 1.44
Gene-specific paradoxical QT responses during rapid eye movement sleep in women with congenital long QT syndrome. Heart Rhythm (2010) 1.43
Sleep and the metabolic syndrome. Exp Physiol (2006) 1.43
Obesity, sleep apnea, and hypertension. Hypertension (2003) 1.41
Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters. Cardiovasc Res (2004) 1.41
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun (2004) 1.40
Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol (2002) 1.40
Electrophysiological properties of prion-positive cardiac progenitors derived from murine embryonic stem cells. Circ J (2012) 1.40
Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol (2015) 1.39
Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation (2005) 1.39
Left atrial branches of coronary arteries; clinical implications related to linear catheter ablation for atrial fibrillation. J Interv Card Electrophysiol (2009) 1.38
Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers. Circ J (2010) 1.38
Brachiocephalic vein perforation on three-dimensional computed tomography. Europace (2007) 1.38
Obstructive sleep apnea: implications for cardiac and vascular disease. Chest (2008) 1.36